Position in EXEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,977
+$1,901 QoQ
Shares Held
165
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#669
of 751 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Colonial Trust Co / SC holds $111,794 across 17 Biotechnology names. EXEL ranks #4 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
106 | $31,909 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29 | $18,082 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21 | $10,431 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
165 | $8,977 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
70 | $5,478 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
14 | $5,203 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
53 | $4,608 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
500 | $4,377 |
All Filings in EXEL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,977 | 165 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $7,076 | 165 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,231 | 165 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,814 | 165 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,319 | 98 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,578 | 124 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $29,603 | 889 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,217 | 124 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||